Back to Careers

Angela Genge, MD, FRCP(c), eMBA


Dr Genge is recognized internationally for her work in clinical trial design and execution in the field of rare disease, particularly Amyotrophic Lateral Sclerosis, Myasthenia Gravis, and FSHD. Currently the Executive Director of the ALS center of excellence at the Montreal Neurological Institute, McGill University, she recently stepped down from executive director of the MNI’s clinical trial unit after a 20 year tenure. She serves as scientific advisor for a number of clinical trial networks including ENCALS , CALS and is a member of the executive committee of the WFN ALS section. Her current activities include CMO of Quralis, Global PI of AL-S Pharma and serves as an advisor to sponsors for ALS, FTD, Myotonic Dystrophy, FSHD and Myasthenia Gravis among many others. A regular invited speaker on many topics from novel therapies in neuroscience to regulatory challenges internationally she has received a number of awards including the Forbes Norris Award, the Wings over Wall Street award, the YWCA woman of distinction, and a founder award from Community Cares. She advocates tirelessly for therapeutic innovation in neuroscience and access to therapeutics for the rare disease community.

Learn more about Angela